Connect with us

Hi, what are you looking for?

Monday, Jun 27, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

Optimi enters natural psilocybin supply agreement with Filament Health

The mushrooms will be grown and distributed from Optimi’s 20,000 square foot EU-GMP facility in Princeton

Optimi's 20,000 square foot EU-GMP cultivation facilities in Princeton, British Columbia.
Optimi's 20,000 square foot EU-GMP cultivation facilities in Princeton, British Columbia. Photo via Optimi

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) is set to start distributing shrooms to a psilocybin-focused pharmaceutical developer.

On Tuesday, the Vancouver-based producer with operations in Princeton, British Columbia announced a partnership with the clinical-stage natural psilocybin developer company Filament Health (OTCQB:FLHLF) (NEO:FH) (FSE:7QS).

Under the agreement, both companies have agreed to a one-year term which would allow Filament to place orders for whole, dried, fruiting body mushrooms on a case-by-case basis.

The mushrooms will be grown and distributed from Optimi’s 20,000 square foot EU-GMP facility in Princeton which is used for drug development, testing and analysis.

Optimi stock went up by 7.14 per cent on Tuesday to $0.38 on the Canadian Securities Exchange.

The company recently signed another deal with Halucenex Life Sciences to deliver the shroom fruiting bodies.

Read more: Optimi Health enters psilocybin mushroom supply agreement with Halucenex Life Sciences

Read more: Havn Life partners with non-profit TheraPsil to bring safe access to psilocybin

“Our supply agreement with Filament Health is an excellent fit for both parties,” Optimi CEO Bill Ciprick said.

“Filament’s commitment to the development of unique intellectual properties using natural psychedelic medicines, and to the advancement of natural psilocybin in the space as a whole, are well-aligned with our own values and goals for the future of psychedelics,” said Ciprick.

Filament CEO Benjamin Lightburn said the company is pleased with the partnership as it builds its own supply chain and explores external suppliers.

“This is an important step for Filament, and we look forward to determining the compatibility of Optimi’s product with our industry-leading natural extraction technology,” Lightburn said.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe